The role of miRNAs and lncRNAs in neurofibromatosis type 1

被引:6
|
作者
Khosravi, Teymoor [1 ]
Oladnabi, Morteza [2 ,3 ,4 ]
机构
[1] Golestan Univ Med Sci, Student Res Comm, Gorgan, Iran
[2] Golestan Univ Med Sci, Gorgan Congenital Malformat Res Ctr, Gorgan, Iran
[3] Golestan Univ Med Sci, Ischem Disorders Res Ctr, Gorgan, Iran
[4] Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Genet, Gorgan 4916978342, Iran
关键词
long noncoding RNA; mircoRNAs; neurofibromatosis type 1; tumourigenesis; NERVE SHEATH TUMORS; ENDOTHELIAL GROWTH-FACTOR; NF1; GENE; MICRORNA; 135; EXPRESSION; TUMORIGENESIS; MUTATIONS; GENOTYPE; BIOGENESIS; REPRESSION;
D O I
10.1002/jcb.30349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis Type 1 (NF1) is a frequent cancer predisposition syndrome. The common hallmark of patients with this multisystemic genetic disorder is the formation of peripheral nerve sheath tumors, which can be seen as either dermal, plexiform, and malignant forms. MicroRNA (miRNA) is an essential gene regulation factor and consists of 22-25 nucleotides. MiRNAs are identified to act as both tumor suppressors and oncogenes (oncomirs) in a wide variety of human cancers. They play multiple roles in molecular pathways responsible for tumor homing, progression, and invasion. Long noncoding RNA (lncRNA) also has a key role in cancer transcriptomics. Altered lncRNA expression levels have been found in various malignancies. This review aims to summarize the role of two noncoding RNA groups, miRNAs and lncRNAs, in NF1 establishment, development, and progression. We also highlight their potential for future clinical interventions and devising new diagnostic tools.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [1] Competing endogenous RNA network analysis explores the key lncRNAs, miRNAs, and mRNAs in type 1 diabetes
    Li, Chang
    Wei, Bo
    Zhao, Jianyu
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [2] The role of lncRNAs/miRNAs/Sirt1 axis in myocardial and cerebral injury
    Barangi, Samira
    Hayes, A. Wallace
    Karimi, Gholamreza
    CELL CYCLE, 2023, 22 (09) : 1062 - 1073
  • [3] Tumorigenesis in neurofibromatosis type 1: role of the microenvironment
    Jiang, Chunhui
    McKay, Renee M.
    Le, Lu Q.
    ONCOGENE, 2021, 40 (39) : 5781 - 5787
  • [4] Advances in Molecular Diagnosis of Neurofibromatosis Type 1
    Shofty, Ben
    Constantini, Shlomi
    Ben-Shachar, Shay
    SEMINARS IN PEDIATRIC NEUROLOGY, 2015, 22 (04) : 234 - 239
  • [5] miRNAs and lncRNAs in reproductive development
    Li, Zhe-Feng
    Zhang, Yu-Chan
    Chen, Yue-Qin
    PLANT SCIENCE, 2015, 238 : 46 - 52
  • [6] Role of miRNAs and lncRNAs in dexamethasone-induced myotube atrophy in vitro
    Li, Yang
    Shi, Huacai
    Chen, Rui
    Zhou, Shanyao
    Lei, Si
    She, Yanling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (02)
  • [7] Competing endogenous RNA network analysis explores the key lncRNAs, miRNAs, and mRNAs in type 1 diabetes
    Chang Li
    Bo Wei
    Jianyu Zhao
    BMC Medical Genomics, 14
  • [8] Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis
    Xu, Hui
    Ni, Yu-Qing
    Liu, You-Shuo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Neurological malignancies in neurofibromatosis type 1
    Eoli, Marica
    Saletti, Veronica
    Finocchiaro, Gaetano
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 554 - 561
  • [10] The systems biology of neurofibromatosis type 1 - Critical roles for microRNA
    Lee, Ming-Jen
    Cho, Ji-Hoon
    Galas, David J.
    Wang, Kai
    EXPERIMENTAL NEUROLOGY, 2012, 235 (02) : 464 - 468